Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
8
×
life sciences
national blog main
texas blog main
texas top stories
8
×
national
national top stories
san francisco blog main
san francisco top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
fda
clinical trials
keytruda
loxo oncology
roche
bristol-myers squibb
larotrectinib
merck
opdivo
yervoy
amgen
cancer immunotherapy
What
cancer
8
×
annual
clinical
drug
medicine
oncology
society
cash
conference
esmo
european
fda
medical
meeting
patients
roundup
seen
today
added
adds
ahead
allison
ambien
american
antonoio
appetite
approved
asco
ash
attendees
attention
barcelona
bio
bioaffinity
biotech
black
board
bread
breast
butter
Language
unset
Current search:
cancer
×
cancer
×
" texas top stories "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@xconomy.com
6 years ago
BioAffinity Seeking $5M for Cancer Diagnostic, Adds Board Member